Literature DB >> 23234395

The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Adriana P Hermida1, William M McDonald, Kyle Steenland, Allan Levey.   

Abstract

Depression, mild cognitive impairment (MCI) and dementia are highly prevalent conditions that are increasing exponentially with similarly expanding social, medical and economic burdens. While there is a clear clinical connection between these three disorders, the mechanism of action that links them is less well understood. The lack of well-accepted biomarkers results in high levels of diagnostic subjectivity, which then greatly impacts research results when attempting to further explore their association. There is also a variety of clinical presentations of depressive syndromes, particularly in the elderly; each one may be associated with a different risk in the progression from MCI to different types of dementia. The diagnostic challenges, the importance of biomarkers and the discussion of inflammation as a possible link between depression, MCI and dementia are examined in this article.

Entities:  

Mesh:

Year:  2012        PMID: 23234395      PMCID: PMC4404497          DOI: 10.1586/ern.12.127

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  105 in total

1.  The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha.

Authors:  B L Fiebich; T J Hofer; K Lieb; M Huell; R D Butcher; G Schumann; K Schulze-Osthoff; J Bauer
Journal:  Neuropharmacology       Date:  1999-09       Impact factor: 5.250

2.  Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.

Authors:  Kyle Steenland; Conny Karnes; Ryan Seals; Claudine Carnevale; Adriana Hermida; Allan Levey
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  The rate of conversion of mild cognitive impairment to dementia: predictive role of depression.

Authors:  T Gabryelewicz; M Styczynska; E Luczywek; A Barczak; A Pfeffer; W Androsiuk; M Chodakowska-Zebrowska; B Wasiak; B Peplonska; M Barcikowska
Journal:  Int J Geriatr Psychiatry       Date:  2007-06       Impact factor: 3.485

4.  Depressive symptoms and risk for dementia: a 9-year follow-up of the Maastricht Aging Study.

Authors:  Sebastian Köhler; Martin van Boxtel; Jelle Jolles; Frans Verhey
Journal:  Am J Geriatr Psychiatry       Date:  2011-10       Impact factor: 4.105

5.  Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia.

Authors:  Emily R Edwards; Adam P Spira; Deborah E Barnes; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

6.  Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.

Authors:  Yonas E Geda; David S Knopman; David A Mrazek; Gregory A Jicha; Glenn E Smith; Selamawit Negash; Bradley F Boeve; Robert J Ivnik; Ronald C Petersen; V Shane Pankratz; Walter A Rocca
Journal:  Arch Neurol       Date:  2006-03

7.  Predictors of progression from mild cognitive impairment to Alzheimer disease.

Authors:  K Palmer; A K Berger; R Monastero; B Winblad; L Bäckman; L Fratiglioni
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

8.  Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment.

Authors:  L Rozzini; B Vicini Chilovi; M Conti; I Delrio; B Borroni; M Trabucchi; A Padovani
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-19       Impact factor: 2.959

9.  Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Authors:  Daniel Lindqvist; Shorena Janelidze; Peter Hagell; Sophie Erhardt; Martin Samuelsson; Lennart Minthon; Oskar Hansson; Maria Björkqvist; Lil Träskman-Bendz; Lena Brundin
Journal:  Biol Psychiatry       Date:  2009-03-06       Impact factor: 13.382

10.  Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Authors:  P H Lu; S D Edland; E Teng; K Tingus; R C Petersen; J L Cummings
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

View more
  31 in total

Review 1.  Current understanding of the neurobiology and longitudinal course of geriatric depression.

Authors:  Sara L Weisenbach; Anand Kumar
Journal:  Curr Psychiatry Rep       Date:  2014-09       Impact factor: 5.285

2.  Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.

Authors:  Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-29       Impact factor: 9.236

Review 3.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

4.  Longitudinal Association of Dementia and Depression.

Authors:  Mark B Snowden; David C Atkins; Lesley E Steinman; Janice F Bell; Lucinda L Bryant; Catherine Copeland; Annette L Fitzpatrick
Journal:  Am J Geriatr Psychiatry       Date:  2014-09-21       Impact factor: 4.105

5.  Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons.

Authors:  Ana W Capuano; Robert S Wilson; William G Honer; Vladislav A Petyuk; Sue E Leurgans; Lei Yu; Jennifer R Gatchel; Steven Arnold; David A Bennett; Zoe Arvanitakis
Journal:  J Affect Disord       Date:  2019-03-08       Impact factor: 4.839

6.  Linking late life depression and Alzheimer's disease: mechanisms and resilience.

Authors:  Sara L Weisenbach; Joseph Kim; Dustin Hammers; Kelly Konopacki; Vincent Koppelmans
Journal:  Curr Behav Neurosci Rep       Date:  2019-07-25

Review 7.  The Use of ECT in the Elderly-Looking Beyond Depression.

Authors:  Anthony N Chatham; Hadia Shafi; Adriana P Hermida
Journal:  Curr Psychiatry Rep       Date:  2022-07-13       Impact factor: 8.081

8.  Serum Soluble Adhesion Molecules and Markers of Systemic Inflammation in Elderly Diabetic Patients with Mild Cognitive Impairment and Depressive Symptoms.

Authors:  Malgorzata Gorska-Ciebiada; Malgorzata Saryusz-Wolska; Anna Borkowska; Maciej Ciebiada; Jerzy Loba
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

9.  The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.

Authors:  Nicole L Cockayne; Shantel L Duffy; Rosalind Bonomally; Amelia English; Paul G Amminger; Andrew Mackinnon; Helen M Christensen; Sharon L Naismith; Ian B Hickie
Journal:  Trials       Date:  2015-06-03       Impact factor: 2.279

10.  Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment.

Authors:  Malgorzata Gorska-Ciebiada; Malgorzata Saryusz-Wolska; Anna Borkowska; Maciej Ciebiada; Jerzy Loba
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.